Selangor Journal
Cough medication is poured in this picture illustration taken on October 19, 2022. — Picture by REUTERS

India launches inquiry into drug company after death of 18 children in Uzbekistan

MOSCOW, Dec 29 — The Indian authorities launched an investigation into the pharmaceutical company Marion Biotech, based in the northern state of Uttar Pradesh, after 18 children died In Uzbekistan as a result of consuming the company’s drugs, Indian media reported on Thursday.

The Uzbek Health Ministry on Tuesday confirmed the death of 18 out of 21 children who consumed the Marion Biotech-produced cough syrup, Doc-1 Max. Laboratory tests revealed the presence of a toxic substance, ethylene glycol, in a batch of syrups. Medical examination materials have been submitted to law enforcement agencies.

India’s Central Drugs Standard Control Organisation and Uttar Pradesh Drugs Controlling and Licensing Authority will conduct a joint inquiry into the incident, Sputnik quoted the NDTV broadcaster report.

According to the Uzbek Health Ministry, the syrup was initially used by the parents as a cold remedy and was given to children without a doctor’s prescription in doses exceeding the standard. The Doc-1 Max tablets and syrups have been withdrawn from all pharmacies across Uzbekistan following the incident, the ministry emphasised.

This is the second such case with India-manufactured cough syrups in 2022. In October, the Gambian government confirmed the death of 70 children from acute kidney failure. The country’s authorities attributed these deaths to the administration of India-manufactured drugs containing toxic substances.

— Bernama

Top Picks

Free tolls on all highways for Aidilfitri on April 8, 9 — Minister

Anwar attends Iftar Madani, breaks fast with nearly 10,000 people

Malaysia committed to reforming economy, embracing innovation — DPM